| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5c25763e978de5a9620a4949021a03e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dd62f55366e233d884953ac30e2a041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b8fd0b02226e0b65e45490a394ccdcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_063639f0ad91f14ef5f433663e493409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8c689ab1a74e2bc8953337169eb69a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_674dc34d563bd91f49fb2aad6d1de6be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7e4849444de3731fcb7b1ca783a691b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 |
| filingDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc0b1a97cdb8a7a0d742c46da94f9fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77466db7eb3276571a497dcccf0f24cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94af2d4a94a50ecf20156d8579787773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e03a99bee366ad6305ffc535520e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5e3150fd753ed883346f4ce9d3fa253 |
| publicationDate |
2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009080849-A2 |
| titleOfInvention |
Genetic markers for the prognosis of multiple sclerosis |
| abstract |
The invention relates to a series of genes, the expression of which is altered in subjects with multiple sclerosis in relation to healthy subjects and in subjects with multiple sclerosis with a good prognosis in relation to subjects with multiple sclerosis with a poor prognosis. The invention is based on an initial set of genes that demonstrate the aforementioned differential expression, from which a subset of 13 genes and two clinical variables was validated, which can be used to predict the course of a patient with high reliability. The invention makes use of said expression values in order to provide methods for prognosticating the course of a patient diagnosed with multiple sclerosis on the basis of tables of conditioned probability between the expression levels of a pre-determined gene or group of genes and the probability values associated with the patient having a good or poor prognosis. |
| priorityDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |